What about Xiamen Encheng Group Co., Ltd.?

Introduction: Xiamen Encheng Group has two biomedical research institutes, a factory and a sales company. Is a comprehensive enterprise focusing on the biomedical field, integrating R&D, production and sales. At present, it has formed a complete industrial chain of independent research and development of new drugs (including research and development of chemical drugs, traditional Chinese medicines, natural medicine raw materials and preparations), raw material extraction, synthetic production, preparation production and drug sales, with a total investment of 200 million yuan, of which R&D investment has exceeded 70 million yuan.

Subordinate subsidiaries: Xiamen Encheng Pharmaceutical Co., Ltd., Beijing Encheng Kangtai Biotechnology Co., Ltd., Fuzhou Changfuxing Biomedical Technology Co., Ltd. and Xiamen Jianxin Medicine (Technology) Co., Ltd.

Our spirit: "Always keep a positive spirit and always pursue technological progress".

Our style: "serious, innovative and persistent".

Our team: "mutual respect, mutual trust, unity and cooperation".

Our goal: "to build a virtuous circle of enterprise mechanism, and strive to become a first-class drug research and development, first-class drug quality, first-class drug sales performance of China science and technology pharmaceutical enterprise group".

I. Xiamen Jianxin Pharmaceutical Technology Co., Ltd.

Registered in 2007, with a registered capital of100,000 yuan, it is located in Guanyinshan International Business Operation Center in Xiamen, with a 5A-level office environment and a fast and convenient transportation network. Acting as an agent for the sales of prescription drugs in the field of professional treatment at home and abroad in the domestic market, and enjoying a certain popularity in the field of professional sales of tumor treatment and digestive system in China.

Second, Xiamen Encheng Pharmaceutical Co., Ltd.

Registered in 2006, the land area is about 40 mu, the total construction area is about 22,939 square meters, and the registered capital is 35 million. Production license for raw materials: 9 varieties including Almeley Tan and moxifloxacin hydrochloride were approved. There is a preparation production license: four dosage forms of tablets, capsules, powders and granules have been approved. 20 14 year declaration: 1 new raw materials and 4 new preparations. 20 15 put into production: the first class 3.2 new chemical drug omeprazole sodium bicarbonate capsule in China. 20 15 declared varieties: 5 new raw materials, 10 new preparations.

3. Beijing Encheng Kangtai Biotechnology Co., Ltd.

Established in 20 12, the research area is1500m2, the investment is more than 50 million yuan, and the R&D team consists of 70 people (50% for master and 50% for doctor, 3 1% for undergraduate and 0/9% for specialist). National high-tech enterprises, Zhongguancun high-tech enterprises, Beijing science and technology research and development institutions, Beijing safety standardization certification enterprises, and public technical service platform of new district (medical quality standardization research service platform).

Fuzhou changfuxing biomedical technology co., ltd.

Founded in 200 1 with an investment of150,000 yuan, it mainly develops new Chinese and western medicines and new varieties of health food, and provides related technology transfer and technical services. Since 2004, it has been recognized as a high-tech enterprise in Fujian Province, and has been supported by special funds from the state, provinces and municipal governments for many times. In 2005, the company settled in Fuzhou Jinshan Science and Technology Enterprise Incubation Park, which is the public technical service platform of Fuzhou Biomedical Incubator. The company's laboratory is listed as the practice base of pharmacy specialty in medical colleges. 19 Chinese medicine projects, 2 chemical medicine projects and 7 invention patents have been declared and passed.

Legal Representative: Wang Bin.

Date of establishment: May 30, 2007

Registered capital: 1.00 million yuan.

Location: Fujian Province

Unified social credit code: 9 1350200798092062T

Business status: surviving (in business, in business, on record)

Industry: leasing and business services

Company type: limited liability company (natural person investment or holding)

Number of employees: 100-499.

Enterprise address: Unit 403, No.0/70 Tapu East Road, Siming District, Xiamen.

Business scope: investment in hotel industry, manufacturing industry, commerce, tourism industry and real estate industry (unless otherwise stipulated by laws and regulations); Real estate development; Property management; Software research and development, and provide related technical services; Business information consultation; Wholesale and retail: machinery and equipment, hardware and electric materials, electronic products, crafts and gifts, chemical products (excluding pre-approval items), building materials, metal materials, daily necessities sales, instruments and meters.